Free Trial

STAAR Surgical (STAA) Stock Forecast & Price Target

$40.07
-0.60 (-1.48%)
(As of 07/26/2024 ET)

STAAR Surgical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 11 Wall Street analysts who have issued ratings for STAAR Surgical in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 1 has given a sell rating, 5 have given a hold rating, and 5 have given a buy rating for STAA.

Consensus Price Target

$48.00
19.79% Upside
High Forecast$57.00
Average Forecast$48.00
Low Forecast$37.00

According to the 11 analysts' twelve-month price targets for STAAR Surgical, the average price target is $48.00. The highest price target for STAA is $57.00, while the lowest price target for STAA is $37.00. The average price target represents a forecasted upside of 19.79% from the current price of $40.07.

TypeCurrent Forecast
7/28/23 to 7/27/24
1 Month Ago
6/28/23 to 6/27/24
3 Months Ago
4/29/23 to 4/28/24
1 Year Ago
7/28/22 to 7/28/23
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
4 Buy rating(s)
7 Buy rating(s)
Hold
5 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$48.00$47.00$46.38$78.90
Forecasted Upside19.79% Upside14.62% Upside10.00% Upside18.55% Upside
Get STAAR Surgical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

STAA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

STAA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

STAAR Surgical Stock vs. The Competition

TypeSTAAR SurgicalMedical CompaniesS&P 500
Consensus Rating Score
2.36
2.72
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside19.79% Upside3,123.46% Upside9.18% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/15/2024BTIG Research
2 of 5 stars
R. Zimmerman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$46.00 ➝ $53.00+17.39%
7/15/2024Needham & Company LLC
3 of 5 stars
 Reiterated RatingHold
7/15/2024Morgan Stanley
3 of 5 stars
 DowngradeEqual Weight ➝ Underweight$50.00 ➝ $37.00-21.46%
5/8/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$46.00 ➝ $43.00+7.58%
5/8/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$33.00 ➝ $40.00+1.24%
5/8/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$53.00 ➝ $55.00+17.90%
4/4/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kaczor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
4/1/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$50.00+28.67%
9/15/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
8/14/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$57.00+35.14%
11/7/2022Sidoti
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
10/14/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$97.00 ➝ $88.00+22.22%
8/11/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$165.00 ➝ $125.00+42.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 02:04 AM ET.

STAA Forecast - Frequently Asked Questions

What is STAAR Surgical's forecast for 2024?

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for STAAR Surgical is $48.00, with a high forecast of $57.00 and a low forecast of $37.00.

Should I buy or sell STAAR Surgical stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There is currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" STAA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.

Does STAAR Surgical's stock price have much upside?

According to analysts, STAAR Surgical's stock has a predicted upside of 10.35% based on their 12-month stock forecasts.

Has STAAR Surgical been upgraded or downgraded by Wall Street analysts recently?

Over the previous 90 days, STAAR Surgical's stock had 1 upgrade and 1 downgrade by analysts.

What analysts cover STAAR Surgical?

STAAR Surgical has been rated by research analysts at BTIG Research, Canaccord Genuity Group, Mizuho, Morgan Stanley, Needham & Company LLC, and Piper Sandler in the past 90 days.

Do Wall Street analysts like STAAR Surgical more than its competitors?

Analysts like STAAR Surgical less than other "medical" companies. The consensus rating for STAAR Surgical is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how STAA compares to other companies.


This page (NASDAQ:STAA) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners